Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Association between snoring and deciduous dental development and soft tissue profile in 3-year-old children.

Niemi P, Markkanen S, Helminen M, Rautiainen M, Katila MK, Saarenpää-Heikkilä O, Peltomäki T.

Am J Orthod Dentofacial Orthop. 2019 Dec;156(6):840-845. doi: 10.1016/j.ajodo.2019.02.015.

PMID:
31784018
2.

Parental reports showed that snoring in infants at three and eight months associated with snoring parents and smoking mothers.

Katila M, Saarenpää-Heikkilä O, Saha MT, Vuorela N, Paavonen EJ.

Acta Paediatr. 2019 Sep;108(9):1686-1694. doi: 10.1111/apa.14758. Epub 2019 Mar 25.

PMID:
30791132
3.

Dysbiosis in Snoring Children: An Interlink to Comorbidities?

Collado MC, Katila MK, Vuorela NM, Saarenpää-Heikkilä O, Salminen S, Isolauri E.

J Pediatr Gastroenterol Nutr. 2019 Feb;68(2):272-277. doi: 10.1097/MPG.0000000000002161.

PMID:
30289820
4.

Patient-reported complications associated with Campylobacter jejuni infection.

Schönberg-Norio D, Mattila L, Lauhio A, Katila ML, Kaukoranta SS, Koskela M, Pajarre S, Uksila J, Eerola E, Sarna S, Rautelin H.

Epidemiol Infect. 2010 Jul;138(7):1004-11. doi: 10.1017/S0950268809991099. Epub 2009 Nov 4.

PMID:
19887016
5.

Intrauterine bacterial growth at birth and risk of asthma and allergic sensitization among offspring at the age of 15 to 17 years.

Keski-Nisula L, Katila ML, Remes S, Heinonen S, Pekkanen J.

J Allergy Clin Immunol. 2009 Jun;123(6):1305-11. doi: 10.1016/j.jaci.2009.03.021. Epub 2009 May 7.

PMID:
19423155
6.

Mycobacteria and fungi in moisture-damaged building materials.

Torvinen E, Meklin T, Torkko P, Suomalainen S, Reiman M, Katila ML, Paulin L, Nevalainen A.

Appl Environ Microbiol. 2006 Oct;72(10):6822-4.

7.

Strain and host characteristics of Campylobacter jejuni infections in Finland.

Schönberg-Norio D, Sarna S, Hänninen ML, Katila ML, Kaukoranta SS, Rautelin H.

Clin Microbiol Infect. 2006 Aug;12(8):754-60.

8.

Activities of telithromycin, erythromycin, fluoroquinolones, and doxycycline against Campylobacter strains isolated from Finnish subjects.

Schönberg-Norio D, Hänninen ML, Katila ML, Kaukoranta SS, Koskela M, Eerola E, Uksila J, Pajarre S, Rautelin H.

Antimicrob Agents Chemother. 2006 Mar;50(3):1086-8.

9.

Infections and bacterial colonization during cytotoxic therapy in patients with acute leukemia.

Perola O, Nousiainen T, Pentikäinen J, Laatikainen A, Katila ML.

Eur J Clin Microbiol Infect Dis. 2005 Nov;24(11):766-8. No abstract available.

PMID:
16328561
10.

Mycobacterium florentinum sp. nov., isolated from humans.

Tortoli E, Rindi L, Goh KS, Katila ML, Mariottini A, Mattei R, Mazzarelli G, Suomalainen S, Torkko P, Rastogi N.

Int J Syst Evol Microbiol. 2005 May;55(Pt 3):1101-6.

PMID:
15879240
11.

Persistent Legionella pneumophila colonization of a hospital water supply: efficacy of control methods and a molecular epidemiological analysis.

Perola O, Kauppinen J, Kusnetsov J, Kärkkäinen UM, Lück PC, Katila ML.

APMIS. 2005 Jan;113(1):45-53.

PMID:
15676014
12.

[Disease spectrum caused by atypical mycobacteria].

Katila ML, Ruokonen EL, Eskola J, Lamberg MA.

Duodecim. 2004;120(18):2240-6. Review. Finnish. No abstract available.

PMID:
15560461
13.

Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey.

Martín-Casabona N, Bahrmand AR, Bennedsen J, Thomsen VO, Curcio M, Fauville-Dufaux M, Feldman K, Havelkova M, Katila ML, Köksalan K, Pereira MF, Rodrigues F, Pfyffer GE, Portaels F, Urgell JR, Rüsch-Gerdes S, Tortoli E, Vincent V, Watt B; Spanish Group for Non-Tuberculosis Mycobacteria.

Int J Tuberc Lung Dis. 2004 Oct;8(10):1186-93.

PMID:
15527150
14.

Swimming and Campylobacter infections.

Schönberg-Norio D, Takkinen J, Hänninen ML, Katila ML, Kaukoranta SS, Mattila L, Rautelin H.

Emerg Infect Dis. 2004 Aug;10(8):1474-7.

15.

Potentially pathogenic, slow-growing mycobacteria released into workplace air during the remediation of buildings.

Rautiala S, Torvinen E, Torkko P, Suomalainen S, Nevalainen A, Kalliokoski P, Katila ML.

J Occup Environ Hyg. 2004 Jan;1(1):1-6.

PMID:
15202150
16.

Mycobacteria in water and loose deposits of drinking water distribution systems in Finland.

Torvinen E, Suomalainen S, Lehtola MJ, Miettinen IT, Zacheus O, Paulin L, Katila ML, Martikainen PJ.

Appl Environ Microbiol. 2004 Apr;70(4):1973-81.

17.
18.

Gas-chromatographic lipid profiles in identification of currently known slowly growing environmental mycobacteria.

Torkko P, Katila ML, Kontro M.

J Med Microbiol. 2003 Apr;52(Pt 4):315-23.

PMID:
12676870
19.

Nosocomial Legionella pneumophila serogroup 5 outbreak associated with persistent colonization of a hospital water system.

Perola O, Kauppinen J, Kusnetsov J, Heikkinen J, Jokinen C, Katila ML.

APMIS. 2002 Dec;110(12):863-8.

PMID:
12645664
20.

Bergeyella zoohelcum septicaemia of a patient suffering from severe skin infection.

Kivinen PK, Lahtinen MR, Ruotsalainen E, Harvima IT, Katila ML.

Acta Derm Venereol. 2003;83(1):74-5. No abstract available.

22.

Detection and typing of Campylobacter jejuni and Campylobacter coli and analysis of indicator organisms in three waterborne outbreaks in Finland.

Hänninen ML, Haajanen H, Pummi T, Wermundsen K, Katila ML, Sarkkinen H, Miettinen I, Rautelin H.

Appl Environ Microbiol. 2003 Mar;69(3):1391-6.

23.

Mycobacterium palustre sp. nov., a potentially pathogenic, slowly growing mycobacterium isolated from clinical and veterinary specimens and from Finnish stream waters.

Torkko P, Suomalainen S, Iivanainen E, Tortoli E, Suutari M, Seppänen J, Paulin L, Katila ML.

Int J Syst Evol Microbiol. 2002 Sep;52(Pt 5):1519-25.

PMID:
12361253
24.

[Enlarged pelvic lymph nodes after immunotherapy in a patient with bladder cancer].

Rissanen AM, Pekonen M, Terho R, Krees R, Katila ML.

Duodecim. 2002;118(10):1029-32. Finnish. No abstract available.

PMID:
12237997
25.

Recurrent Sphingomonas paucimobilis -bacteraemia associated with a multi-bacterial water-borne epidemic among neutropenic patients.

Perola O, Nousiainen T, Suomalainen S, Aukee S, Kärkkäinen UM, Kauppinen J, Ojanen T, Katila ML.

J Hosp Infect. 2002 Mar;50(3):196-201.

PMID:
11886195
26.

Comparison of mycobacteria-induced cytotoxicity and inflammatory responses in human and mouse cell lines.

Huttunen K, Jussila J, Hirvonen MR, Iivanainen E, Katila ML.

Inhal Toxicol. 2001 Nov;13(11):977-91.

PMID:
11696869
27.

[An unexplained cancer disease and bone metastases].

Keski-Nisula L, Katila ML, Virén M, Kataja V, Katila T.

Duodecim. 1998;114(8):777-81. Finnish. No abstract available.

PMID:
11524794
28.

Pulmonary infection caused by an unusual, slowly growing nontuberculous Mycobacterium.

Suomalainen S, Koukila-Kähkölä P, Brander E, Katila ML, Piilonen A, Paulin L, Mattson K.

J Clin Microbiol. 2001 Jul;39(7):2668-71.

29.

PCR-based typing of Mycobacterium avium isolates in an epidemic among farmed lesser white-fronted geese (Anser erythropus).

Kauppinen J, Hintikka E, Iivanainen E, Katila M.

Vet Microbiol. 2001 Jul 3;81(1):41-50.

PMID:
11356317
30.

Tuberculosis as an occupational hazard for health care workers in Estonia.

Krüüner A, Danilovitsh M, Pehme L, Laisaar T, Hoffner SE, Katila ML.

Int J Tuberc Lung Dis. 2001 Feb;5(2):170-6.

PMID:
11258511
31.

Characterization of Mycobacterium bohemicum isolated from human, veterinary, and environmental sources.

Torkko P, Suomalainen S, Iivanainen E, Suutari M, Paulin L, Rudbäck E, Tortoli E, Vincent V, Mattila R, Katila ML.

J Clin Microbiol. 2001 Jan;39(1):207-11.

32.

Recurrence of urinary tract infections in adult patients with community-acquired pyelonephritis caused by E. coli: a 1-year follow-up.

Kärkkäinen UM, Ikäheimo R, Katila ML, Siitonen A.

Scand J Infect Dis. 2000;32(5):495-9.

PMID:
11055653
33.

Characterisation of a new isolate of Mycobacterium shimoidei from Finland.

Koukila-Kähkölä P, Paulin L, Brander E, Jantzen E, Eho-Remes M, Katila ML.

J Med Microbiol. 2000 Oct;49(10):937-40.

PMID:
11023191
34.

Inflammatory responses in RAW264.7 macrophages caused by mycobacteria isolated from moldy houses.

Huttunen K, Ruotsalainen M, Iivanainen E, Torkko P, Katila M, Hirvonen M.

Environ Toxicol Pharmacol. 2000 Jun 1;8(4):237-244.

PMID:
10996543
35.

Intrauterine inflammation at term: a histopathologic study.

Keski-Nisula L, Aalto ML, Katila ML, Kirkinen P.

Hum Pathol. 2000 Jul;31(7):841-6.

PMID:
10923922
36.

Low virulence of Escherichia coli strains causing urinary tract infection in renal disease patients.

Kärkkäinen UM, Ikäheimo R, Katila ML, Sivonen A, Siitonen A.

Eur J Clin Microbiol Infect Dis. 2000 Apr;19(4):254-9.

PMID:
10834813
37.

Mycobacterium xenopi and related organisms isolated from stream waters in Finland and description of Mycobacterium botniense sp. nov.

Torkko P, Suomalainen S, Iivanainen E, Suutari M, Tortoli E, Paulin L, Katila ML.

Int J Syst Evol Microbiol. 2000 Jan;50 Pt 1:283-9.

PMID:
10826815
38.

Development of tuberculin reactivity and sensitization to M. scrofulaceum and M. fortuitum in children BCG-vaccinated at birth.

Kröger L, Korppi M, Pelkonen J, Pietikäinen M, Katila ML.

Eur Respir J. 2000 Feb;15(2):382-7.

39.

Accelerated detection and identification of mycobacteria with MGIT 960 and COBAS AMPLICOR systems.

Katila ML, Katila P, Erkinjuntti-Pekkanen R.

J Clin Microbiol. 2000 Mar;38(3):960-4.

40.

Hospital water supply as a source of disseminated Mycobacterium fortuitum infection in a leukemia patient.

Kauppinen J, Nousiainen T, Jantunen E, Mattila R, Katila ML.

Infect Control Hosp Epidemiol. 1999 May;20(5):343-5.

PMID:
10349952
41.

Isolation of mycobacteria from indoor swimming pools in Finland.

Iivanainen E, Northrup J, Arbeit RD, Ristola M, Katila ML, von Reyn CF.

APMIS. 1999 Feb;107(2):193-200.

PMID:
10225317
42.

Environmental factors affecting the occurrence of mycobacteria in brook sediments.

Iivanainen E, Martikainen PJ, Väänänen P, Katila ML.

J Appl Microbiol. 1999 Apr;86(4):673-81.

43.
44.

Clinical relevance of Ureaplasma urealyticum colonization in preterm infants.

Ollikainen J, Heiskanen-Kosma T, Korppi M, Katila ML, Heinonen K.

Acta Paediatr. 1998 Oct;87(10):1075-8.

PMID:
9825976
45.

Separation among species of Mycobacterium terrae complex by lipid analyses: comparison with biochemical tests and 16S rRNA sequencing.

Torkko P, Suutari M, Suomalainen S, Paulin L, Larsson L, Katila ML.

J Clin Microbiol. 1998 Feb;36(2):499-505.

46.

Amniotic fluid U. urealyticum colonization: significance for maternal peripartal infections at term.

Keski-Nisula L, Kirkinen P, Katila ML, Ollikainen M, Suonio S, Saarikoski S.

Am J Perinatol. 1997 Mar;14(3):151-6.

PMID:
9259918
47.

Cesarean delivery. Microbial colonization in amniotic fluid.

Keski-Nisula L, Kirkinen P, Katila ML, Ollikainen M, Saarikoski S.

J Reprod Med. 1997 Feb;42(2):91-8.

PMID:
9058344
48.

Amniotic fluid leukocytes and leukocyte esterase activity in parturients delivered by caesarean section.

Keski-Nisula L, Katila ML, Kirkinen P, Ollikainen M, Saarikoski S.

Scand J Infect Dis. 1997;29(3):291-6.

PMID:
9255892
49.
50.

Histopathological and bacteriological findings in prurigo nodularis.

Mattila JO, Vornanen M, Katila ML.

Acta Derm Venereol. 1997 Jan;77(1):49-51.

Supplemental Content

Loading ...
Support Center